drugset / Trial / NCT01868802

Ketamine for Treatment-resistant Depression: A Multicentric Clinical Trial in Mexican Population

NCT01868802 ↗

Phase 2 Unknown 60 enrolled Paul J. Lamothe
RandomizedParallel-groupTriple-blindTreatment

Summary

A randomized multicentric parallel arms study involving the use of ketamine for treatment-resistant depression will be held at three national health provider clinics in the Mexican population. The purpose of this study is to determine whether clinical response seen in previous studies is replicable in this population.

Timeline

Start
2013-09
Primary completion
2016-05
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.5 mg/kg Intravenous

Indications